Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ADMA
BEAM
Add up to 3 more stocks
ADMA
ADMA Biologics, Inc.
+1.07%
$10.22+0.11Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$2.37B
52W Range
$7.21 - $25.67
BEAM
Beam Therapeutics Inc.
-2.18%
$25.11-0.56Delayed quote: Oct 6, 2026, 1:15 PM EDT
Market Cap
$2.58B
52W Range
$20.23 - $38.26
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 14.60 | N/A |
| Forward P/E | 12.83 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.80 | 2.42 |
| P/S Ratio | 4.62 | 16.56 |
| P/FCF Ratio | 20.33 | N/A |
| EV/EBITDA | 10.78 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 64.7% | 84.0% |
| Operating Margin | 42.3% | -274.6% |
| Net Margin | 33.0% | -54.8% |
| ROE | 41.4% | -8.0% |
| ROA | 24.7% | -6.2% |
| ROIC | 27.6% | -29.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 6.97 | 14.57 |
| Quick Ratio | 3.81 | 14.57 |
| Debt/Equity | 0.50 | 0.23 |
| Interest Coverage | 26.93 | -8.77 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.